SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (5553)9/9/1998 8:38:00 PM
From: Claud B  Read Replies (2) of 7041
 
Linda,

I don't think the run-up in the stock was related to an injectible
form of the drug. I have no knowledge about that.

What I DO think contributed is the probable acceptance of the NDA
by the FDA within 3 or 4 days from now....which will trigger another
$5 million payment by SGP.

Don't know if you recall but perhaps 8 or 9 months ago, I posted
here that it was impossible to argue with those on opposing sides.
At that time, I said that the shorts would probably have an opposite
view to the future accomplishments of Zonagen no matter what the news.

As I recall, I said " NDA will be filed....shorts say yes, but it
won't be accepted.....FDA will approve Vasomax....shorts respond with
yes, but it won't sell."

One of your posts earlier today falls right into that prediction.

Claud
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext